# Relmada Therapeutics, Inc.: Form DEF 14A, filed Jan 31, 2020

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: DEF 14A
- Filed: 2020-01-31
- Accepted by EDGAR: Jan 31, 2020, 16:27 ET
- Period: 2020-03-06
- Accession: 0001213900-20-002274
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390020002274/def14a0120_relmadatherap.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390020002274/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390020002274/def14a0120_relmadatherap.htm

Filed Jan 31, 2020.
Source: SEC EDGAR, the filing index for accession 0001213900-20-002274. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
